Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 09 - 16    symbols : ABBV    save search

Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06
Published: 2021-09-16 (Crawled : 23:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.02% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.47% C: -0.15%
CHRS | $2.02 -7.34% -7.39% 630K twitter stocktwits trandingview |
Health Technology
| | O: -0.7% H: 2.3% C: 2.23%

positive results
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
Published: 2021-09-16 (Crawled : 23:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.02% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%
CHRS | $2.02 -7.34% -7.39% 630K twitter stocktwits trandingview |
Health Technology
| | O: 1.12% H: 0.0% C: 0.0%

treatment positive therapy results phase 3 trial cell carcinoma
Global $314 Billion Healthcare Contract Development & Manufacturing Organization (CDMO) Market to 2026
Published: 2021-09-16 (Crawled : 15:15) - prnewswire.com
TMO | News | $577.39 0.49% -0.38% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.12% C: -0.3%
JBL F | $120.24 -0.54% -1.47% 1.4M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.18% H: 1.1% C: 0.03%
ABBV | News | $167.8 -1.03% -0.02% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.47% C: -0.15%

contract
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2021-09-16 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.02% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.47% C: -0.15%

treatment fda ema ulcerative colitis
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.